GlaxoSmithKline (GSK)
GlaxoSmithKline News
Attention, Investors: It's Time to Sell
Fool about 2 hours agoHealthcare Business Recap: Human Genome Sciences Shareholder Sues, Endo Health Kisses Watson Pharmaceuticals
about 6 hours agoAmarin Corporation plc (AMRN) Ramps on Lovaza News
Street Insider about 9 hours agoInPlay: GlaxoSmithKline: CDRD and CDRD ventures enter into a collaboration with GSK to advance the development and commercialization of Canadian Health Research
about 9 hours agoTeva (TEVA), Par Pharma (NPRX) said to lose bid to sell the generic form of Glaxo's (GSK) Lovaza
Street Insider about 9 hours agoThe new workplace revolution: Wage and hour lawsuits
about 10 hours agoAuxilium Pharma Sues Watson
about 12 hours ago4 Pharmaceuticals To Buy Now For Profits In 2013
about 13 hours agoTeva Issues 2012 Outlook
about 13 hours agoTeva Issues 2012 Outlook - Analyst Blog
Zacks about 13 hours agoTeva, which saw a change in leadership recently, finally provided much-awaited guidance for 2012.
Glaxo moves cancer drug to Phase III
about 14 hours agoHuman Genome Shareholder Seeks to Block Poison Pill
about 15 hours agoUPDATE: Citi Raises GlaxoSmithKline's PT
Benzinga about 15 hours agoHuman Genome shareholder sues board over GSK "poison pill," Reuters reports
about 17 hours agoYou may also be interested in these GSK related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| GSK | 44.38 | +0.10 | +0.23% | 111.75B |
| GSIT | 4.18 | -0.02 | -0.48% | 120.25M |
| GSIG | 11.98 | +0.13 | +1.10% | 397.09M |
| GSI | 0.9874 | +0.12 | +13.48% | |
| GSH | 16.41 | +0.11 | +0.67% | 2.314B |
| GSB | 2.06 | -0.09 | -4.19% | 39.15M |
| GSAT | 0.391 | -0.01 | -3.43% | 120.61M |
| GS | 97.82 | +1.12 | +1.16% | 47.86B |
| GRZ | 3.40 | +0.11 | +3.34% | 195.89M |
| GRX | 8.14 | +0.04 | +0.49% |
